{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:38:02Z","timestamp":1793410682240,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Aging"],"DOI":"10.1038\/s43587-025-00965-4","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T09:03:19Z","timestamp":1757494999000},"page":"2104-2124","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Plasma proteomic associations with Alzheimer\u2019s disease endophenotypes"],"prefix":"10.1038","volume":"5","author":[{"given":"Shiva","family":"Afshar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2947-7606","authenticated-orcid":false,"given":"Eric B.","family":"Dammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijia","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3765-6287","authenticated-orcid":false,"given":"Richard","family":"Mohs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doug","family":"Beauregard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chadwick M.","family":"Hales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia C.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7596-9831","authenticated-orcid":false,"given":"Monica W.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine R.","family":"Trammell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6574-0833","authenticated-orcid":false,"given":"Caroline M.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1867-7071","authenticated-orcid":false,"given":"Todd E.","family":"Golde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4507-624X","authenticated-orcid":false,"given":"Nicholas T.","family":"Seyfried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5466-0053","authenticated-orcid":false,"given":"Blaine R.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecelia M.","family":"Manzanares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8810-620X","authenticated-orcid":false,"given":"James J.","family":"Lah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3153-502X","authenticated-orcid":false,"given":"Allan I.","family":"Levey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0604-2944","authenticated-orcid":false,"given":"Erik C. B.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"key":"965_CR1","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr.","year":"2024","unstructured":"Jack, C. R. Jr. et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement. 20, 5143\u20135169 (2024).","journal-title":"Alzheimers Dement."},{"key":"965_CR2","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims, J. R. et al. Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA 330, 512\u2013527 (2023).","journal-title":"JAMA"},{"key":"965_CR3","doi-asserted-by":"crossref","unstructured":"van Dyck, C. H. et al. Lecanemab in early Alzheimer\u2019s disease. N. Engl. J. Med. 388, 9\u201321 (2022).","DOI":"10.1056\/NEJMoa2212948"},{"key":"965_CR4","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/alz.12748","volume":"19","author":"MS Rafii","year":"2023","unstructured":"Rafii, M. S. et al. The AHEAD 3-45 study: design of a prevention trial for Alzheimer\u2019s disease. Alzheimers Dement. 19, 1227\u20131233 (2023).","journal-title":"Alzheimers Dement."},{"key":"965_CR5","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/ana.23964","volume":"74","author":"PA Boyle","year":"2013","unstructured":"Boyle, P. A. et al. Much of late life cognitive decline is not due to common neurodegenerative pathologies. Ann. Neurol. 74, 478\u2013489 (2013).","journal-title":"Ann. Neurol."},{"key":"965_CR6","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1016\/S2666-7568(23)00019-3","volume":"4","author":"E Nichols","year":"2023","unstructured":"Nichols, E. et al. The prevalence, correlation, and co-occurrence of neuropathology in old age: harmonisation of 12 measures across six community-based autopsy studies of dementia. Lancet Healthy Longev. 4, e115\u2013e125 (2023).","journal-title":"Lancet Healthy Longev."},{"key":"965_CR7","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","volume":"69","author":"JA Schneider","year":"2007","unstructured":"Schneider, J. A., Arvanitakis, Z., Bang, W. & Bennett, D. A. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 69, 2197\u20132204 (2007).","journal-title":"Neurology"},{"key":"965_CR8","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr.","year":"2018","unstructured":"Jack, C. R. Jr. et al. NIA-AA Research Framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 14, 535\u2013562 (2018).","journal-title":"Alzheimers Dement."},{"key":"965_CR9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41593-021-00999-y","volume":"25","author":"ECB Johnson","year":"2022","unstructured":"Johnson, E. C. B. et al. Large-scale deep multi-layer analysis of Alzheimer\u2019s disease brain reveals strong proteomic disease-related changes not observed at the RNA level. Nat. Neurosci. 25, 213\u2013225 (2022).","journal-title":"Nat. Neurosci."},{"key":"965_CR10","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.neuron.2025.02.014","volume":"113","author":"M Ali","year":"2025","unstructured":"Ali, M. et al. Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures across the Alzheimer disease continuum. Neuron 113, 1363\u20131379 (2025).","journal-title":"Neuron"},{"key":"965_CR11","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13195-022-01113-5","volume":"14","author":"EB Dammer","year":"2022","unstructured":"Dammer, E. B. et al. Multi-platform proteomic analysis of Alzheimer\u2019s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome. Alzheimers Res. Ther. 14, 174 (2022).","journal-title":"Alzheimers Res. Ther."},{"key":"965_CR12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adn3504","volume":"16","author":"EB Dammer","year":"2024","unstructured":"Dammer, E. B. et al. Proteomic analysis of Alzheimer\u2019s disease cerebrospinal fluid reveals alterations associated with APOE \u03b54 and atomoxetine treatment. Sci. Transl. Med. 16, eadn3504 (2024).","journal-title":"Sci. Transl. Med."},{"key":"965_CR13","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/s43587-022-00300-1","volume":"2","author":"M Del Campo","year":"2022","unstructured":"Del Campo, M. et al. CSF proteome profiling across the Alzheimer\u2019s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels. Nat. Aging 2, 1040\u20131053 (2022).","journal-title":"Nat. Aging"},{"key":"965_CR14","doi-asserted-by":"crossref","first-page":"eaaz9360","DOI":"10.1126\/sciadv.aaz9360","volume":"6","author":"L Higginbotham","year":"2020","unstructured":"Higginbotham, L. et al. Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer\u2019s disease. Sci. Adv. 6, eaaz9360 (2020).","journal-title":"Sci. Adv."},{"key":"965_CR15","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1038\/s41593-024-01737-w","volume":"27","author":"A Pichet Binette","year":"2024","unstructured":"Pichet Binette, A. et al. Proteomic changes in Alzheimer\u2019s disease associated with progressive A\u03b2 plaque and tau tangle pathologies. Nat. Neurosci. 27, 1880\u20131891 (2024).","journal-title":"Nat. Neurosci."},{"key":"965_CR16","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/s43587-024-00693-1","volume":"4","author":"EA Frick","year":"2024","unstructured":"Frick, E. A. et al. Serum proteomics reveal APOE-\u03b54-dependent and APOE-\u03b54-independent protein signatures in Alzheimer\u2019s disease. Nat. Aging 4, 1446\u20131464 (2024).","journal-title":"Nat. Aging"},{"key":"965_CR17","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1038\/s41591-023-02476-4","volume":"29","author":"ECB Johnson","year":"2023","unstructured":"Johnson, E. C. B. et al. Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer\u2019s disease. Nat. Med. 29, 1979\u20131988 (2023).","journal-title":"Nat. Med."},{"key":"965_CR18","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adf5681","volume":"15","author":"KA Walker","year":"2023","unstructured":"Walker, K. A. et al. Proteomics analysis of plasma from middle-aged adults identifies protein markers of dementia risk in later life. Sci. Transl. Med. 15, eadf5681 (2023).","journal-title":"Sci. Transl. Med."},{"key":"965_CR19","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s43587-021-00064-0","volume":"1","author":"KA Walker","year":"2021","unstructured":"Walker, K. A. et al. Large-scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk. Nat. Aging 1, 473\u2013489 (2021).","journal-title":"Nat. Aging"},{"key":"965_CR20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","volume":"12","author":"B Dubois","year":"2016","unstructured":"Dubois, B. et al. Preclinical Alzheimer\u2019s disease: definition, natural history, and diagnostic criteria. Alzheimers Dement. 12, 292\u2013323 (2016).","journal-title":"Alzheimers Dement."},{"key":"965_CR21","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","volume":"87","author":"CR Jack Jr.","year":"2016","unstructured":"Jack, C. R. Jr. et al. A\/T\/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology 87, 539\u2013547 (2016).","journal-title":"Neurology"},{"key":"965_CR22","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1056\/NEJMoa2310168","volume":"390","author":"J Jia","year":"2024","unstructured":"Jia, J. et al. Biomarker changes during 20 years preceding Alzheimer\u2019s disease. N. Engl. J. Med. 390, 712\u2013722 (2024).","journal-title":"N. Engl. J. Med."},{"key":"965_CR23","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","volume":"404","author":"G Livingston","year":"2024","unstructured":"Livingston, G. et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet 404, 572\u2013628 (2024).","journal-title":"Lancet"},{"key":"965_CR24","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1001\/jamaneurol.2016.3185","volume":"73","author":"J Middeldorp","year":"2016","unstructured":"Middeldorp, J. et al. Preclinical assessment of young blood plasma for Alzheimer disease. JAMA Neurol. 73, 1325\u20131333 (2016).","journal-title":"JAMA Neurol."},{"key":"965_CR25","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1002\/alz.13722","volume":"20","author":"RC Mohs","year":"2024","unstructured":"Mohs, R. C. et al. The Bio-Hermes study: biomarker database developed to investigate blood-based and digital biomarkers in community-based, diverse populations clinically screened for Alzheimer\u2019s disease. Alzheimers Dement. 20, 2752\u20132765 (2024).","journal-title":"Alzheimers Dement."},{"key":"965_CR26","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.3233\/JAD-179939","volume":"64","author":"DA Bennett","year":"2018","unstructured":"Bennett, D. A. et al. Religious Orders Study and Rush Memory and Aging Project. J. Alzheimers Dis. 64, S161\u2013S189 (2018).","journal-title":"J. Alzheimers Dis."},{"key":"965_CR27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","volume":"12","author":"VL Villemagne","year":"2013","unstructured":"Villemagne, V. L. et al. Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study. Lancet Neurol. 12, 357\u2013367 (2013).","journal-title":"Lancet Neurol."},{"key":"965_CR28","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-40208-x","volume":"14","author":"M Askenazi","year":"2023","unstructured":"Askenazi, M. et al. Compilation of reported protein changes in the brain in Alzheimer\u2019s disease. Nat. Commun. 14, 4466 (2023).","journal-title":"Nat. Commun."},{"key":"965_CR29","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","volume":"26","author":"ECB Johnson","year":"2020","unstructured":"Johnson, E. C. B. et al. Large-scale proteomic analysis of Alzheimer\u2019s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat. Med. 26, 769\u2013780 (2020).","journal-title":"Nat. Med."},{"key":"965_CR30","volume":"5","author":"Y Levites","year":"2024","unstructured":"Levites, Y. et al. Integrative proteomics identifies a conserved A\u03b2 amyloid responsome, novel plaque proteins, and pathology modifiers in Alzheimer\u2019s disease. Cell Rep. Med. 5, 101669 (2024).","journal-title":"Cell Rep. Med."},{"key":"965_CR31","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1002\/alz.13821","volume":"20","author":"AM Wojtas","year":"2024","unstructured":"Wojtas, A. M. et al. Proteomic changes in the human cerebrovasculature in Alzheimer\u2019s disease and related tauopathies linked to peripheral biomarkers in plasma and cerebrospinal fluid. Alzheimers Dement. 20, 4043\u20134065 (2024).","journal-title":"Alzheimers Dement."},{"key":"965_CR32","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1146\/annurev-immunol-101921-035222","volume":"42","author":"A Mary","year":"2024","unstructured":"Mary, A., Mancuso, R. & Heneka, M. T. Immune activation in Alzheimer disease. Annu. Rev. Immunol. 42, 585\u2013613 (2024).","journal-title":"Annu. Rev. Immunol."},{"key":"965_CR33","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/s43587-024-00643-x","volume":"4","author":"M Kivim\u00e4ki","year":"2024","unstructured":"Kivim\u00e4ki, M. & Walker, K. A. Severe infections as a gateway to dementia. Nat. Aging 4, 752\u2013754 (2024).","journal-title":"Nat. Aging"},{"key":"965_CR34","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/s43587-024-00621-3","volume":"4","author":"LS Richmond-Rakerd","year":"2024","unstructured":"Richmond-Rakerd, L. S. et al. Associations of hospital-treated infections with subsequent dementia: nationwide 30-year analysis. Nat. Aging 4, 783\u2013790 (2024).","journal-title":"Nat. Aging"},{"key":"965_CR35","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ebiom.2018.10.021","volume":"37","author":"A Alam","year":"2018","unstructured":"Alam, A., Hana, Z., Jin, Z., Suen, K. C. & Ma, D. Surgery, neuroinflammation and cognitive impairment. EBioMedicine 37, 547\u2013556 (2018).","journal-title":"EBioMedicine"},{"key":"965_CR36","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41586-023-05788-0","volume":"615","author":"X Chen","year":"2023","unstructured":"Chen, X. et al. Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy. Nature 615, 668\u2013677 (2023).","journal-title":"Nature"},{"key":"965_CR37","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41586-019-1895-7","volume":"577","author":"D Gate","year":"2020","unstructured":"Gate, D. et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer\u2019s disease. Nature 577, 399\u2013404 (2020).","journal-title":"Nature"},{"key":"965_CR38","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3390\/biomedicines12020308","volume":"12","author":"M Yamakawa","year":"2024","unstructured":"Yamakawa, M. & Rexach, J. E. Cell states and interactions of CD8 T cells and disease-enriched microglia in human brains with Alzheimer\u2019s disease. Biomedicines 12, 308 (2024).","journal-title":"Biomedicines"},{"key":"965_CR39","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00702-021-02411-2","volume":"129","author":"N Gomez de San Jose","year":"2022","unstructured":"Gomez de San Jose, N. et al. Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration. J. Neural Transm. (Vienna) 129, 207\u2013230 (2022).","journal-title":"J. Neural Transm. (Vienna)"},{"key":"965_CR40","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1002\/alz.12353","volume":"17","author":"O Libiger","year":"2021","unstructured":"Libiger, O. et al. Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer\u2019s disease. Alzheimers Dement. 17, 1976\u20131987 (2021).","journal-title":"Alzheimers Dement."},{"key":"965_CR41","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adf0141","volume":"15","author":"J Zhou","year":"2023","unstructured":"Zhou, J. et al. The neuronal pentraxin Nptx2 regulates complement activity and restrains microglia-mediated synapse loss in neurodegeneration. Sci. Transl. Med. 15, eadf0141 (2023).","journal-title":"Sci. Transl. Med."},{"key":"965_CR42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s43587-024-00780-3","volume":"5","author":"ECB Johnson","year":"2025","unstructured":"Johnson, E. C. B. Plasma proteins associated with the brain age gap. Nat. Aging 5, 15\u201316 (2025).","journal-title":"Nat. Aging"},{"key":"965_CR43","first-page":"99","volume":"5","author":"WS Liu","year":"2025","unstructured":"Liu, W. S. et al. Plasma proteomics identify biomarkers and undulating changes of brain aging. Nat. Aging 5, 99\u2013112 (2025).","journal-title":"Nat. Aging"},{"key":"965_CR44","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41593-020-0635-5","volume":"23","author":"AP Wingo","year":"2020","unstructured":"Wingo, A. P. et al. Shared proteomic effects of cerebral atherosclerosis and Alzheimer\u2019s disease on the human brain. Nat. Neurosci. 23, 696\u2013700 (2020).","journal-title":"Nat. Neurosci."},{"key":"965_CR45","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13023","volume":"18","author":"P Sebastiani","year":"2019","unstructured":"Sebastiani, P. et al. A serum protein signature of APOE genotypes in centenarians. Aging Cell 18, e13023 (2019).","journal-title":"Aging Cell"},{"key":"965_CR46","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1093\/eurheartj\/ehz402","volume":"40","author":"KL Rasmussen","year":"2019","unstructured":"Rasmussen, K. L., Tybjaerg-Hansen, A., Nordestgaard, B. G. & Frikke-Schmidt, R. Plasma levels of apolipoprotein E, APOE genotype, and all-cause and cause-specific mortality in 105 949 individuals from a white general population cohort. Eur. Heart J. 40, 2813\u20132824 (2019).","journal-title":"Eur. Heart J."},{"key":"965_CR47","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ana.24326","volume":"77","author":"KL Rasmussen","year":"2015","unstructured":"Rasmussen, K. L., Tybjaerg-Hansen, A., Nordestgaard, B. G. & Frikke-Schmidt, R. Plasma levels of apolipoprotein E and risk of dementia in the general population. Ann. Neurol. 77, 301\u2013311 (2015).","journal-title":"Ann. Neurol."},{"key":"965_CR48","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1126\/science.aaq1327","volume":"361","author":"V Emilsson","year":"2018","unstructured":"Emilsson, V. et al. Co-regulatory networks of human serum proteins link genetics to disease. Science 361, 769\u2013773 (2018).","journal-title":"Science"},{"key":"965_CR49","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1038\/s41588-024-01972-8","volume":"56","author":"D Western","year":"2024","unstructured":"Western, D. et al. Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer\u2019s disease. Nat. Genet. 56, 2672\u20132684 (2024).","journal-title":"Nat. Genet."},{"key":"965_CR50","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cub.2003.12.058","volume":"14","author":"ML McCleland","year":"2004","unstructured":"McCleland, M. L. et al. The vertebrate Ndc80 complex contains Spc24 and Spc25 homologs, which are required to establish and maintain kinetochore-microtubule attachment. Curr. Biol. 14, 131\u2013137 (2004).","journal-title":"Curr. Biol."},{"key":"965_CR51","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/B978-0-12-407757-7.00011-6","volume":"115","author":"G Tian","year":"2013","unstructured":"Tian, G. & Cowan, N. J. Tubulin-specific chaperones: components of a molecular machine that assembles the \u03b1\/\u03b2 heterodimer. Methods Cell Biol. 115, 155\u2013171 (2013).","journal-title":"Methods Cell Biol."},{"key":"965_CR52","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","volume":"81","author":"NJ Ashton","year":"2024","unstructured":"Ashton, N. J. et al. Diagnostic accuracy of a plasma phosphorylated tau 217 immunoassay for Alzheimer disease pathology. JAMA Neurol. 81, 255\u2013263 (2024).","journal-title":"JAMA Neurol."},{"key":"965_CR53","doi-asserted-by":"crossref","first-page":"6506","DOI":"10.1002\/alz.14140","volume":"20","author":"DJ Figdore","year":"2024","unstructured":"Figdore, D. J. et al. Optimizing cutpoints for clinical interpretation of brain amyloid status using plasma p-tau217 immunoassays. Alzheimers Dement. 20, 6506\u20136516 (2024).","journal-title":"Alzheimers Dement."},{"key":"965_CR54","doi-asserted-by":"crossref","first-page":"e70003","DOI":"10.1002\/dad2.70003","volume":"16","author":"RZ Rousset","year":"2024","unstructured":"Rousset, R. Z. et al. Performance of plasma p-tau217 and NfL in an unselected memory clinic setting.Alzheimers Dement. (Amst.) 16, e70003 (2024).","journal-title":"Alzheimers Dement. (Amst.)"},{"key":"965_CR55","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13195-021-00939-9","volume":"13","author":"S Bayoumy","year":"2021","unstructured":"Bayoumy, S. et al. Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231. Alzheimers Res. Ther. 13, 198 (2021).","journal-title":"Alzheimers Res. Ther."},{"key":"965_CR56","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/acn3.51695","volume":"10","author":"TF Tropea","year":"2023","unstructured":"Tropea, T. F. et al. Plasma phosphorylated tau181 predicts cognitive and functional decline. Ann. Clin. Transl. Neurol. 10, 18\u201331 (2023).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"965_CR57","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.jalz.2018.01.010","volume":"14","author":"O Hansson","year":"2018","unstructured":"Hansson, O. et al. CSF biomarkers of Alzheimer\u2019s disease concord with amyloid-\u03b2 PET and predict clinical progression: a study of fully automated immunoassays in BioFINDER and ADNI cohorts. Alzheimers Dement. 14, 1470\u20131481 (2018).","journal-title":"Alzheimers Dement."},{"key":"965_CR58","volume":"5","author":"L Gold","year":"2010","unstructured":"Gold, L. et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS ONE 5, e15004 (2010).","journal-title":"PLoS ONE"},{"key":"965_CR59","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1373\/jalm.2018.027086","volume":"4","author":"A Tin","year":"2019","unstructured":"Tin, A. et al. Reproducibility and variability of protein analytes measured using a multiplexed modified aptamer assay. J. Appl. Lab. Med. 4, 30\u201339 (2019).","journal-title":"J. Appl. Lab. Med."},{"key":"965_CR60","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22116-0","volume":"12","author":"J Candia","year":"2022","unstructured":"Candia, J., Daya, G. N., Tanaka, T., Ferrucci, L. & Walker, K. A. Assessment of variability in the plasma 7k SomaScan proteomics assay. Sci. Rep. 12, 17147 (2022).","journal-title":"Sci. Rep."},{"key":"965_CR61","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","volume":"324","author":"S Palmqvist","year":"2020","unstructured":"Palmqvist, S. et al. Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders. JAMA 324, 772\u2013781 (2020).","journal-title":"JAMA"},{"key":"965_CR62","doi-asserted-by":"crossref","first-page":"1092341","DOI":"10.3389\/fsysb.2023.1092341","volume":"3","author":"EB Dammer","year":"2023","unstructured":"Dammer, E. B., Seyfried, N. T. & Johnson, E. C. B. Batch correction and harmonization of -omics datasets with a tunable median polish of ratio. Front. Syst. Biol. 3, 1092341 (2023).","journal-title":"Front. Syst. Biol."},{"key":"965_CR63","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1186\/s12859-016-1323-z","volume":"17","author":"GE Hoffman","year":"2016","unstructured":"Hoffman, G. E. & Schadt, E. E. variancePartition: interpreting drivers of variation in complex gene expression studies. BMC Bioinformatics 17, 483 (2016).","journal-title":"BMC Bioinformatics"},{"key":"965_CR64","doi-asserted-by":"crossref","unstructured":"Seabold, S. & Perktold, J. Statsmodels: econometric and statistical modeling with Python. In Proc. 9th Python in Science Conference 57\u201361 (SciPy, 2010).","DOI":"10.25080\/Majora-92bf1922-011"},{"key":"965_CR65","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/biom.13214","volume":"76","author":"ZR McCaw","year":"2020","unstructured":"McCaw, Z. R., Lane, J. M., Saxena, R., Redline, S. & Lin, X. Operating characteristics of the rank-based inverse normal transformation for quantitative trait analysis in genome-wide association studies. Biometrics 76, 1262\u20131272 (2020).","journal-title":"Biometrics"},{"key":"965_CR66","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1093\/bioinformatics\/btq340","volume":"26","author":"CJ Willer","year":"2010","unstructured":"Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190\u20132191 (2010).","journal-title":"Bioinformatics"}],"container-title":["Nature Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43587-025-00965-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-025-00965-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-025-00965-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:58:50Z","timestamp":1760623130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43587-025-00965-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":66,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["965"],"URL":"https:\/\/doi.org\/10.1038\/s43587-025-00965-4","relation":{},"ISSN":["2662-8465"],"issn-type":[{"value":"2662-8465","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,10]]},"assertion":[{"value":"5 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N.T.S. and A.I.L. are founders of EmTheraPro. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}